The filing is a routine tax-related sale by an officer exercising stock options. The small size relative to market cap and the cashless exercise mechanism suggest no material insider sentiment signal. Monitor for any larger insider sales or changes in officer holdings in future filings.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 11 $105.81entry
- T+1 · 5d ago −0.01%α +0.34% · $105.80
- T+3 · todayOpen
- T+5 · tomorrow Pending
- T+20 · in 23d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Daniel J. Lippis, an officer of Edwards Lifesciences, filed a Form 144 notice of intent to sell 1,857 shares of common stock, with an approximate market value of $193,592. The shares are to be sold to cover taxes upon exercise of employee stock options via a cashless exercise. The sale is routine and small relative to the company's $58.7B market cap.
Key Facts
- Insider: Daniel J. Lippis, an officer of Edwards Lifesciences
- Shares to be sold: 1,857 shares of common stock
- Approximate value: $193,592
- Sale method: Broker payment for cashless exercise of employee stock options
- Filing date: November 10, 2026
- Market cap of EW: $58.7B
Financial Impact
Approximately $193,592 worth of shares, representing less than 0.001% of market cap
Risk Factors
- Form 144 is an intent to sell; the actual sale may not occur
- Insider selling could be perceived negatively if it becomes a pattern
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001921094-26-001156 |
| Document: 0001921094-26-001156-index.html | 0001921094-26-001156 |
| Document: 0001921094-26-001156.txt | 0001921094-26-001156 |
Track record
27 reports on EW
1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +4.94% at T+5 after the Nov 4, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 10, 20266d ago 144 Neutral 2/10 Viewing Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 3/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 4, 202612d ago 8-K Bullish 6/10 Entry $100.82 to $105.80 Now $107.11 +6.24% ▲ +4.94% +1.65% vs SPY
- Oct 29, 202618d ago Institutional Cluster Neutral 3/10 Entry $94.44 to $100.82 Now $107.11 +13.42% ▲ +6.76% +11.48% vs SPY
- Aug 31, 202611w ago Insider Cluster Neutral 2/10 Entry $90.74 to $86.18 Now $107.11 +18.04% ▼ −5.03% −5.11% vs SPY
- Aug 28, 202611w ago Insider Cluster Neutral 2/10 Entry $90.75 to $86.72 Now $107.11 +18.03% ▼ −4.44% −4.30% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers